AstraZeneca Pharma India Statistics

Total Valuation

AstraZeneca Pharma India has a market cap or net worth of INR 162.42 billion. The enterprise value is 157.62 billion.

Market Cap	162.42B
Enterprise Value	157.62B

Important Dates

The next estimated earnings date is Tuesday, February 4, 2025.

Earnings Date	Feb 4, 2025
Ex-Dividend Date	Jul 5, 2024

Share Statistics

AstraZeneca Pharma India has 25.00 million shares outstanding. The number of shares has decreased by -0.03% in one year.

Current Share Class	n/a
Shares Outstanding	25.00M
Shares Change (YoY)	-0.03%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	7.93%
Owned by Institutions (%)	7.23%
Float	4.16M

Valuation Ratios

The trailing PE ratio is 198.23.

PE Ratio	198.23
Forward PE	n/a
PS Ratio	10.94
PB Ratio	23.91
P/TBV Ratio	23.98
P/FCF Ratio	1,952.18
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 100.49, with an EV/FCF ratio of 1,894.53.

EV / Earnings	192.41
EV / Sales	10.62
EV / EBITDA	100.49
EV / EBIT	115.66
EV / FCF	1,894.53

Financial Position

The company has a current ratio of 2.25, with a Debt / Equity ratio of 0.03.

Current Ratio	2.25
Quick Ratio	1.36
Debt / Equity	0.03
Debt / EBITDA	0.11
Debt / FCF	2.06
Interest Coverage	136.28

Financial Efficiency

Return on equity (ROE) is 12.28% and return on invested capital (ROIC) is 12.56%.

Return on Equity (ROE)	12.28%
Return on Assets (ROA)	7.27%
Return on Capital (ROIC)	12.56%
Revenue Per Employee	18.56M
Profits Per Employee	1.02M
Employee Count	940
Asset Turnover	1.27
Inventory Turnover	2.54

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +39.84% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+39.84%
50-Day Moving Average	6,989.84
200-Day Moving Average	6,409.51
Relative Strength Index (RSI)	39.09
Average Volume (20 Days)	861

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AstraZeneca Pharma India had revenue of INR 14.85 billion and earned 819.20 million in profits. Earnings per share was 32.77.

Revenue	14.85B
Gross Profit	6.60B
Operating Income	1.36B
Pretax Income	1.11B
Net Income	819.20M
EBITDA	1.54B
EBIT	1.36B
Earnings Per Share (EPS)	32.77

Full Income Statement

Balance Sheet

The company has 4.97 billion in cash and 171.20 million in debt, giving a net cash position of 4.80 billion or 191.86 per share.

Cash & Cash Equivalents	4.97B
Total Debt	171.20M
Net Cash	4.80B
Net Cash Per Share	191.86
Equity (Book Value)	6.79B
Book Value Per Share	271.70
Working Capital	5.92B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 168.70 million and capital expenditures -85.50 million, giving a free cash flow of 83.20 million.

Operating Cash Flow	168.70M
Capital Expenditures	-85.50M
Free Cash Flow	83.20M
FCF Per Share	3.33

Full Cash Flow Statement

Margins

Gross margin is 44.46%, with operating and profit margins of 9.18% and 5.52%.

Gross Margin	44.46%
Operating Margin	9.18%
Pretax Margin	7.45%
Profit Margin	5.52%
EBITDA Margin	10.36%
EBIT Margin	9.18%
FCF Margin	0.56%

Dividends & Yields

This stock pays an annual dividend of 24.00, which amounts to a dividend yield of 0.37%.

Dividend Per Share	24.00
Dividend Yield	0.37%
Dividend Growth (YoY)	50.00%
Years of Dividend Growth	2
Payout Ratio	73.24%
Buyback Yield	0.03%
Shareholder Yield	0.40%
Earnings Yield	0.50%
FCF Yield	0.05%

Dividend Details

Stock Splits

The last stock split was on June 15, 2006. It was a forward split with a ratio of 5.

Last Split Date	Jun 15, 2006
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a